Aligned Genetics, Inc. (KOSDAQ:238120)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,375.00
-240.00 (-5.20%)
At close: Mar 9, 2026
43.44%
Market Cap 61.50B
Revenue (ttm) 17.35B
Net Income (ttm) 3.74B
Shares Out 14.06M
EPS (ttm) 263.63
PE Ratio 16.60
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 75,892
Average Volume 459,624
Open 4,420.00
Previous Close 4,615.00
Day's Range 4,220.00 - 4,500.00
52-Week Range 2,870.00 - 6,050.00
Beta 0.38
RSI 50.16
Earnings Date Mar 16, 2026

About Aligned Genetics

Aligned Genetics, Inc. offers cellular imaging and biomolecular analysis solutions worldwide. It also provides molecular diagnostic solutions for rapid results under the Genescale name; and advanced imaging and analysis solutions under the Logos Biosystems name. The company was formerly known as Logos Biosystems, Inc. and changed its name to Aligned Genetics, Inc. in September 2020. Aligned Genetics, Inc. was founded in 2008 and is headquartered in Anyang-Si, South Korea. [Read more]

Industry Laboratory Analytical Instruments
Founded 2008
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 238120
Full Company Profile

Financial Performance

In 2024, Aligned Genetics's revenue was 15.78 billion, an increase of 3.70% compared to the previous year's 15.21 billion. Earnings were 4.13 billion, an increase of 27.57%.

Financial Statements

News

There is no news available yet.